Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 26 Triple Negative Breast Neoplasms 13 Prostatic Neoplasms 12 Ovarian Neoplasms 12 Neoplasms 10 Neoplasm Metastasis 8 Fallopian Tube Neoplasms 6 Leukemia, Myeloid, Acute 5 Small Cell Lung Carcinoma 4 Pancreatic Neoplasms 4 Endometrial Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Advanced Solid Tumors 4 Carcinoma, Renal Cell 3 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma, Ewing 2 Recurrence 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Lung Neoplasms 2 Carcinoma, Ovarian Epithelial 2 mCRPC 1 Wilms Tumor 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Triple Negative Metastatic Breast Cancer 1 Thrombocythemia, Essential 1 Solid Tumor 1 Sarcoma 1

Interventions

Injections 26 toripalimab 17 pembrolizumab 17 tislelizumab 12 Gemcitabine 8 Cisplatin 7 spartalizumab 6 atezolizumab 6 Irinotecan 6 Carboplatin 6 Paclitaxel 5 Oxaliplatin 5 Nivolumab 5 Leucovorin 5 Fluorouracil 5 camrelizumab 4 Pemetrexed 4 Docetaxel 4 Cetuximab 4 Capecitabine 4 trastuzumab deruxtecan 3 sintilimab 3 olaparib 3 lenvatinib 3 cediranib 3 PM 01183 3 Drug Therapy 3 Cyclophosphamide 3 Bevacizumab 3 Albumin-Bound Paclitaxel 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced Solid Tumor × talazoparib × Clear all

NCT04497116 2025-10-21

TRESR

Repare Therapeutics

Phase 1/2 Completed

276 enrolled 33 charts

Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡